Jump to content

Definition:Product approval

From Insurer Brain
Revision as of 21:12, 13 March 2026 by PlumBot (talk | contribs) (Bot: Creating new article from JSON)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Product approval is the regulatory process through which an insurer obtains authorization to market and sell a new or modified insurance product within a given jurisdiction. This process exists to protect consumers by ensuring that policy forms, rates, and coverage terms meet legal standards for fairness, adequacy, and clarity before products reach the market. The intensity of regulatory review varies dramatically across markets, ranging from strict prior-approval regimes to more permissive file-and-use or use-and-file systems.

📑 In the United States, product approval is governed at the state level, and each state's department of insurance sets its own filing requirements. Some states require prior approval of rates and forms before a product can be sold, while others allow insurers to begin using rates upon filing, subject to subsequent regulatory review. The NAIC's System for Electronic Rates & Forms Filing (SERFF) provides a centralized filing platform, but approval timelines and standards remain state-specific. In the European Union, Solvency II emphasizes the product oversight and governance framework, requiring insurers to operate a formal product approval process that identifies the target market and assesses potential consumer harm — without necessarily mandating prior regulatory sign-off on individual products. Markets in Asia take varying approaches: China's NFRA maintains a prior-approval system for many product categories, while Singapore and Hong Kong adopt more principles-based approaches with targeted intervention powers.

🏗️ For insurers and insurtechs bringing new products to market, the approval process is a critical path item that directly affects speed-to-market and competitive positioning. A slow or unpredictable approval process can delay product launches by months, while noncompliance with filing requirements can result in fines, cease-and-desist orders, or mandatory premium refunds. MGAs developing proprietary products under delegated authority must coordinate closely with their capacity partners to ensure filings align with the carrier's compliance obligations. As products become more innovative — encompassing parametric triggers, embedded distribution, and usage-based models — regulators face the challenge of applying existing frameworks to structures that do not fit neatly into traditional product categories.

Related concepts: